| Document Date: 2014-10-21 07:11:38
Open Document File Size: 28,45 KBShare Result on Facebook
City Tokyo / / Company Astellas Pharma Inc. / Medivation Inc. / / Country Japan / United States / / Currency USD / / Event Business Partnership / FDA Phase / / IndustryTerm pharmaceuticals / manufacturing / pharmaceutical / treatment of advanced castration-resistant prostate cancer / Prostate Cancer Treatment / / MedicalCondition advanced prostate cancer / advanced castration-resistant prostate cancer / prostate cancer / advanced breast cancer / thrombocytopenia / / MedicalTreatment chemotherapy / / / Position global category leader / / Product XTANDI / Japan / / Technology chemotherapy / / URL www.astellas.com/en / /
SocialTag |
Astellas Contact: Corporate Communications +[removed]Astellas Announces Revision of Package Insert in Japan for XTANDI® (enzalutamide) Capsules, a Prostate Cancer Treatment